Slide 1What Is the Role for Analyses of Administrative Data in Assessing Drug Safety in Post-Market Commitment (PMC) Studies? Cathy W. Critchlow, PhD Global Epidemiology,…

Slide 1Medications Development Update The Division of Treatment Research and Development National Institute on Drug Abuse National Advisory Council On Drug Abuse May 22,…

IAEAInternational Atomic Energy Agency RADIATION PROTECTION INDIAGNOSTIC ANDINTERVENTIONAL RADIOLOGYL16.2: Optimization of Protection in FluoroscopyIAEA Training Material…

Slide 1 Assessing the Safety of Marketed Drugs Current Issues and Controversies Captain Paul J. Seligman, M.D., MPH Associate Director, Safety Policy and Communication Center…

Slide 1 Medications For The Treatment Of Opiate Dependence In The US Current Therapies And New Developments WHO Meeting April 2002 Ahmed Elkashef, M.D. Clinical Trials Branch,…

Proposed study design CPOE Reducing Inappropriate Transfusions (CRIT) Collaborative âThe most cost effective opportunity to improve patient outcomes in the next quarter…